What top creators are saying about Centessa Pharmaceuticals plc(CNTA)

Biopharmaceutical company

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 2 scored insights about Centessa Pharmaceuticals plc.

Strongly bullish
avg +0.85
2 bullish0 neutral0 bearish

Top creators covering Centessa Pharmaceuticals plc (CNTA)

The 2 sources with the most insights about Centessa Pharmaceuticals plc on Kazuha.

Latest insights about Centessa Pharmaceuticals plc (CNTA)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, June 29, 2026

Very Bullish
Target: $6.3 billion acquisition

Recently acquired by Eli Lilly for its promising Orexin pathway treatments.

Very Bullish
Target: $6.3B acquisition

Acquired by Eli Lilly; central to the high-potential 'lifestyle drug' market for sleep reduction.

Discussed alongside Centessa Pharmaceuticals plc (CNTA)

Other assets that creators frequently mention in the same content as Centessa Pharmaceuticals plc.

Frequently asked

Which podcasters and creators cover Centessa Pharmaceuticals plc (CNTA) the most?

The most active sources covering Centessa Pharmaceuticals plc (CNTA) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Centessa Pharmaceuticals plc (CNTA) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Centessa Pharmaceuticals plc (CNTA) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Centessa Pharmaceuticals plc (CNTA)?

Creators covering Centessa Pharmaceuticals plc (CNTA) most frequently also discuss BABA, IBM, LLY, RGTI, QBTS. See the "Discussed alongside" section above for full asset pages.